Tag: Revance

BRC Therapeutics Appoints Ron Eastman to Board of Directors

Veteran Pharma Executive and Healthcare Investor Brings More Than 40 Years of Drug Development, Operations and Investment ExperienceMONTEREY, Calif., June 12, 2026 /PRNewswire/ -- BRC...

Crown Laboratories, a Revance Company, Ranks No. 3,991 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies

With Three-Year Revenue Growth of 91%, this Marks the Company's 12th Appearance on the List NASHVILLE, Tenn., Aug. 12, 2025 /PRNewswire/ -- Crown Laboratories, Inc., a...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsRevance

CALX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Calix (CALX) Investors of Securities Class Action Lawsuit Deadline on July 27, 2026

FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch

Hozpitality Celebrates Hospitality Excellence at the Middle East Chef Excellence Awards, F&B Excellence Awards and Leaders Powerlist 2026

Tag: Revance

BRC Therapeutics Appoints Ron Eastman to Board of Directors

Crown Laboratories, a Revance Company, Ranks No. 3,991 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us